View in EDS HTML Full Text PDF Full Text

The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study.

Saved in:
Bibliographic Details
Title: The efficacy of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics in modulating gut microbiota and reducing the risk of the characteristics of metabolic syndrome: A randomized, double-blinded, placebo-controlled study.
Authors: Luangphiphat, Wongsakorn1,2 (AUTHOR), Prombutara, Pinidphon3,4 (AUTHOR), Jamjuree, Praewpannarai5 (AUTHOR), Chantarangkul, Chantanapa5 (AUTHOR), Vitheejongjaroen, Porntipha5 (AUTHOR), Muennarong, Chantaluck5 (AUTHOR), Fukfon, Krittapat6 (AUTHOR), Onwan, Manasvin7,8 (AUTHOR), Taweechotipatr, Malai5,8,9 (AUTHOR) malai@g.swu.ac.th
Source: PLoS ONE. 1/10/2025, Vol. 20 Issue 1, p1-23. 23p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0317202